223 related articles for article (PubMed ID: 16084128)
41. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
42. Comparison of toxicogenomic profiles of two murine strains treated with HIV-1-based vectors for gene therapy.
Zhao Y; Keating K; Thorpe R
Toxicol Appl Pharmacol; 2007 Dec; 225(2):189-97. PubMed ID: 17904176
[TBL] [Abstract][Full Text] [Related]
43. In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency.
Carbonaro DA; Jin X; Petersen D; Wang X; Dorey F; Kil KS; Aldrich M; Blackburn MR; Kellems RE; Kohn DB
Mol Ther; 2006 Jun; 13(6):1110-20. PubMed ID: 16651028
[TBL] [Abstract][Full Text] [Related]
44. Lentiviral vector gene transfer into human T cells.
Verhoeyen E; Costa C; Cosset FL
Methods Mol Biol; 2009; 506():97-114. PubMed ID: 19110622
[TBL] [Abstract][Full Text] [Related]
45. Non-primate lentiviral vectors.
Poeschla EM
Curr Opin Mol Ther; 2003 Oct; 5(5):529-40. PubMed ID: 14601523
[TBL] [Abstract][Full Text] [Related]
46. Analysis of lenti- and trans-lentiviral vector genetic recombination.
Wu X; Wakefield JK; Liu H; Kappes JC
Dev Biol (Basel); 2001; 106():237-48; discussion 249, 253-63. PubMed ID: 11761237
[TBL] [Abstract][Full Text] [Related]
47. Engineered lentiviral vector targeting astrocytes in vivo.
Colin A; Faideau M; Dufour N; Auregan G; Hassig R; Andrieu T; Brouillet E; Hantraye P; Bonvento G; Déglon N
Glia; 2009 Apr; 57(6):667-79. PubMed ID: 18942755
[TBL] [Abstract][Full Text] [Related]
48. Efficient ex vivo gene transfer into non-human primate hepatocytes using HIV-1 derived lentiviral vectors.
Parouchev A; Nguyen TH; Dagher I; Mainot S; Groyer-Picard MT; Branger J; Gonin P; Di Santo J; Franco D; Gras G; Weber A
J Hepatol; 2006 Jul; 45(1):99-107. PubMed ID: 16723167
[TBL] [Abstract][Full Text] [Related]
49. Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier.
Grüter O; Kostic C; Crippa SV; Perez MT; Zografos L; Schorderet DF; Munier FL; Arsenijevic Y
Gene Ther; 2005 Jun; 12(11):942-7. PubMed ID: 15772686
[TBL] [Abstract][Full Text] [Related]
50. Intrapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery.
Tarantal AF; McDonald RJ; Jimenez DF; Lee CC; O'Shea CE; Leapley AC; Won RH; Plopper CG; Lutzko C; Kohn DB
Mol Ther; 2005 Jul; 12(1):87-98. PubMed ID: 15963924
[TBL] [Abstract][Full Text] [Related]
51. FIV: from lentivirus to lentivector.
Saenz DT; Poeschla EM
J Gene Med; 2004 Feb; 6 Suppl 1():S95-104. PubMed ID: 14978754
[TBL] [Abstract][Full Text] [Related]
52. Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy.
Themis M; May D; Coutelle C; Newbold RF
Gene Ther; 2003 Sep; 10(19):1703-11. PubMed ID: 12923569
[TBL] [Abstract][Full Text] [Related]
53. Lentiviral vectors for the treatment of neurodegenerative diseases.
Martin-Rendon E; Azzouz M; Mazarakis ND
Curr Opin Mol Ther; 2001 Oct; 3(5):476-81. PubMed ID: 11699892
[TBL] [Abstract][Full Text] [Related]
54. In vivo gene delivery by lentiviral vectors.
Naldini L
Thromb Haemost; 1999 Aug; 82(2):552-4. PubMed ID: 10605750
[No Abstract] [Full Text] [Related]
55. Fetal and neonatal gene therapy: benefits and pitfalls.
Waddington SN; Kennea NL; Buckley SM; Gregory LG; Themis M; Coutelle C
Gene Ther; 2004 Oct; 11 Suppl 1():S92-7. PubMed ID: 15454963
[TBL] [Abstract][Full Text] [Related]
56. Upscaling of lentiviral vector production by tangential flow filtration.
Geraerts M; Michiels M; Baekelandt V; Debyser Z; Gijsbers R
J Gene Med; 2005 Oct; 7(10):1299-310. PubMed ID: 15906396
[TBL] [Abstract][Full Text] [Related]
57. Ocular gene delivery using lentiviral vectors.
Balaggan KS; Ali RR
Gene Ther; 2012 Feb; 19(2):145-53. PubMed ID: 22052240
[TBL] [Abstract][Full Text] [Related]
58. Monitoring for potential adverse effects of prenatal gene therapy: use of large animal models with relevance to human application.
Mehta V; Abi-Nader KN; Carr D; Wallace J; Coutelle C; Waddington SN; Peebles D; David AL
Methods Mol Biol; 2012; 891():291-328. PubMed ID: 22648778
[TBL] [Abstract][Full Text] [Related]
59. [Progress in improvement of lentiviral vectors' transcriptional read-through].
He J; Zhang J
Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1541-8. PubMed ID: 22393708
[TBL] [Abstract][Full Text] [Related]
60. Current status of gene therapy strategies to treat HIV/AIDS.
Strayer DS; Akkina R; Bunnell BA; Dropulic B; Planelles V; Pomerantz RJ; Rossi JJ; Zaia JA
Mol Ther; 2005 Jun; 11(6):823-42. PubMed ID: 15922953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
